1-9 of 9
troponin, increased
Close
Sort by
Journal Articles

Cardiac Injury and Microvascular Ischemia in Sickle Cell Disease

Kiranveer Kaur, Ying Huang, MS, MA, Subha Raman, MD MS, Eric H. Kraut, MD, Payal Desai, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2286.
https://doi.org/10.1182/blood-2019-125445
Published: 2019
Journal Articles

Describing the Point Prevalence and Characteristics of Venous Thromboembolism in Patients with Thrombotic Thrombocytopenic Purpura

Brandon Tse, Gloria Lim, MDFRCPC,MSc, Michelle Sholzberg, MDBSc,FRCPC,MSc, Katerina Pavenski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2381.
https://doi.org/10.1182/blood-2019-123081
Published: 2019
Journal Articles

Myocardial Ischemia in Patients with Sickle Cell Disease: A Retrospective Review

Payal C. Desai, MD, Nicole Kendel, MS, Spero R Cataland, MD, Eric H. Kraut, MD, Ying Huang, MA, MS, Subha Raman, MD
Journal: Blood
Blood (2015) 126 (23): 2189.
https://doi.org/10.1182/blood.V126.23.2189.2189
Published: 2015
Journal Articles

Hyperleukocytosis Caused By Neulasta Complicated By Leukostasis Versus Asymptomatic Uncomplicated Hyperleukocytosis In AML. Two Cases and When To Leukapherese

Nikhil Jaiswal, Undergraduate Pre-Med, Ahsan Khan, Undergraduate Pre-Med, Zahida Yasin, MD
Journal: Blood
Blood (2013) 122 (21): 4832.
https://doi.org/10.1182/blood.V122.21.4832.4832
Published: 2013
Journal Articles

Hospitalization or Outpatient Treatment for Acute Pulmonary Embolism - a Retrospective Cohort Study of 439 Consecutive Patients with Community-Aquired Pulmonary Embolism

Sebastian Werth, MD, Virginia Kamvissi, Eberhard Kuhlisch, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2012) 120 (21): 3416.
https://doi.org/10.1182/blood.V120.21.3416.3416
Published: 2012
Journal Articles

Evaluation of the Acute Coronary Syndrome Safety Profile of Dabigatran Etexilate in Patients Undergoing Major Orthopaedic Surgery: Findings From Four Phase III Trials

Bengt I Eriksson, MD, John J Smith, MD, PhD, Joseph Caprini, MD, Stefan Hantel, PhD, Andreas Clemens, MD, Martin Feuring, MD, Gregory W Barsness, MD
Journal: Blood
Blood (2011) 118 (21): 2309.
https://doi.org/10.1182/blood.V118.21.2309.2309
Published: 2011
Journal Articles

Immune Ablation Using Cyclophosphamide without Stem Cell Rescue for Intractable Multiple Sclerosis and Its Variants

Julie R Nangia, Jamile M. Shammo, MD, Shilpa D Tilwalli, Roumen Balabanov, Dusan Stefoski, George Katsamakis, Michael Ko, Neel B Shah, Mohamed I Farhat, Alla Gimelfarb, Kathryn Shell, Katherine Bueschel, Stephanie A. Gregory
Journal: Blood
Blood (2008) 112 (11): 4903.
https://doi.org/10.1182/blood.V112.11.4903.4903
Published: 2008
Journal Articles

Should Troponin Level Be an Exclusion Criterion for Stem Cell Transplantation in Primary Amyloidosis?.

Morie Abraham Gertz, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji K. Kumar, MD, Francis Buadi, MD, Nelson Leung, MD, Mark R. Litzow
Journal: Blood
Blood (2007) 110 (11): 3003.
https://doi.org/10.1182/blood.V110.11.3003.3003
Published: 2007
Journal Articles

Phase 1, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Intravenous Alvespimycin (KOS-1022) in Patients with Refractory Hematological Malignancies.

Jeffrey Lancet, MD, Maria R. Baer, MD, Ivana Gojo, MD, M. Burton, M. Quinn, S.M. Tighe, Kapil Bhalla, MD, K. Kersey, S. Wells, Z. Zhong, PhD, B. Sadler, Maher Albitar, MD, Robert Johnson, MD, PhD, Alison Hannah, MBBS
Journal: Blood
Blood (2006) 108 (11): 1961.
https://doi.org/10.1182/blood.V108.11.1961.1961
Published: 2006